The DEEP project has received research funding from the European Union under the 7th Framework Programme

News

QuBo, the multicenter observational transversal study for patients involved in the DEEP-2 trial

Ottobre 30, 2015
|
Comments off
|

The Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) has recently launched the multicenter observational transversal study “Quality evaluation of the informative booklets for patients involved in the DEEP-2 trial” (QuBo). The overall aim of this study is to investigate the quality of the informative material addressed to […]

Share
Read more →

The Story of the project as described in the Scientific report to the EC

Ottobre 30, 2015
|
Comments off
|

The most important achievements and activities carried out by the project have been collected and included in the DEEP Scientific Report related to the period from 01/01/2014 to 30/06/2015 which has been submitted to the European Commission on September 2015.

The report provided a […]

Share
Read more →

DEEP-3: an update on the observational study

Ottobre 30, 2015
|
Comments off
|

DEEP-3 is a long-term observational safety study which evaluates the nature and incidence of adverse effects of deferiprone (DFP) in children and adolescents with beta-thalassaemia major and currently involves 18 recruiting centres from 7 different countries: Albania, Cyprus, Greece, Egypt, Italia, Morocco and Tunisia.

On […]

Share
Read more →

Update of Centres involved

Agosto 3, 2015
|
Comments off
|

Another step forward has been made toward the enrollment of new patients, which is allowed by the end of October 2015.

Principal Investigators (PIs) are still working to continue the enrollment of patients within the DEEP-2 study and to date a total of 117 patients have been […]

Share
Read more →